Your browser doesn't support javascript.
loading
Contemporary prevalence of diabetic neuropathies in individuals with type 1 and type 2 diabetes in a Danish tertiary outpatient clinic.
Mizrak, Hatice Isik; Kufaishi, Huda; Hecquet, Sofie Korsgaard; Hansen, Tine Willum; Pop-Busui, Rodica; Rossing, Peter; Brock, Birgitte; Hansen, Christian Stevns.
Afiliación
  • Mizrak HI; Steno Diabetes Center Copenhagen, Denmark. Electronic address: hatice.isik.mizrak@regionh.dk.
  • Kufaishi H; Steno Diabetes Center Copenhagen, Denmark.
  • Hecquet SK; Steno Diabetes Center Copenhagen, Denmark.
  • Hansen TW; Steno Diabetes Center Copenhagen, Denmark.
  • Pop-Busui R; Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, USA.
  • Rossing P; Steno Diabetes Center Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Brock B; Steno Diabetes Center Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Hansen CS; Steno Diabetes Center Copenhagen, Denmark.
J Diabetes Complications ; 38(6): 108761, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38692039
ABSTRACT

BACKGROUND:

Population-based prevalence estimates of distal symmetric polyneuropathy (DPN) and diabetic autonomic neuropathy (DAN) are scares. Here we present neuropathy estimates and describe their overlap in a large cohort of people with type 1 and type 2 diabetes.

METHODS:

In a large population of outpatient participants, DPN was assessed using vibration perception threshold, sural nerve function, touch, pain and thermal sensation. Definite DPN was defined by the Toronto Consensus Criteria. Painful DPN was defined by Douleur Neuropathique 4 Questions. DAN measures were cardiovascular reflex tests, electrochemical skin conductance, and gastroparesis cardinal symptom index.

RESULTS:

We included 822 individuals with type 1 (mean age (±SD) 54 ± 16 years, median [IQR] diabetes duration 26 [15-40] years) and 899 with type 2 diabetes (mean age 67 ± 11 years, median diabetes duration 16 [11-22] years). Definite DPN was prevalent in 54 % and 68 %, and painful DPN was in 5 % and 15 % of type 1 and type 2 participants, respectively. The prevalence of DAN varied between 6 and 39 % for type 1 and 9-49 % for type 2 diabetes. DPN without other neuropathy was present in 45 % with T1D and 50 % with T2D.

CONCLUSION:

The prevalence of DPN and DAN was high. DPN and DAN co-existed in only 50 % of cases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Neuropatías Diabéticas Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Diabetes Complications Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Neuropatías Diabéticas Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Diabetes Complications Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos